 | | LV9 | | Name: | N-(4-benzyloxan-4-yl)-N'-(pyridin-3-yl)urea | | Formula: | C18 H21 N3 O2 | | SMILES: | O=C(NC1(CCOCC1)Cc1ccccc1)Nc1cccnc1 | | InChi: | InChI=1S/C18H21N3O2/c22-17(20-16-7-4-10-19-14-16)21-18(8-11-23-12-9-18)13-15-5-2-1-3-6-15/h1-7,10,14H,8-9,11-13H2,(H2,20,21,22) | | Definition date: | 2023-08-15 | | Last modified: | 2023-11-03 | | Release date: | 2023-11-08 | | Identifier: | N-(4-benzyloxan-4-yl)-N'-(pyridin-3-yl)urea |
|
 | | LVM | | Name: | N-(4-methylpyridin-3-yl)-2-(spiro[2.3]hexan-5-yl)acetamide | | Formula: | C14 H18 N2 O | | SMILES: | O=C(Nc1cnccc1C)CC1CC2(CC2)C1 | | InChi: | InChI=1S/C14H18N2O/c1-10-2-5-15-9-12(10)16-13(17)6-11-7-14(8-11)3-4-14/h2,5,9,11H,3-4,6-8H2,1H3,(H,16,17) | | Definition date: | 2023-08-15 | | Last modified: | 2023-11-03 | | Release date: | 2023-11-08 | | Identifier: | N-(4-methylpyridin-3-yl)-2-(spiro[2.3]hexan-5-yl)acetamide |
|
 | | LVN | | Name: | (3S)-4-oxo-L-valine | | Formula: | C5 H9 N O3 | | SMILES: | C[CH](C=O)[CH](N)C(O)=O | | InChi: | InChI=1S/C5H9NO3/c1-3(2-7)4(6)5(8)9/h2-4H,6H2,1H3,(H,8,9)/t3-,4+/m1/s1 | | Synonyms: | (2S,3S)-2-amino-3-methyl-4-oxo-butanoic acid | | Definition date: | 2009-11-29 | | Last modified: | 2023-11-03 | | Identifier: | (2S,3S)-2-azanyl-3-methyl-4-oxo-butanoic acid |
|
 | | LW6 | | Name: | 1H-indole-4-carbaldehyde | | Formula: | C9 H7 N O | | SMILES: | O=Cc1cccc2[NH]ccc12 | | InChi: | InChI=1S/C9H7NO/c11-6-7-2-1-3-9-8(7)4-5-10-9/h1-6,10H | | Definition date: | 2023-08-15 | | Last modified: | 2023-11-03 | | Release date: | 2023-11-08 | | Identifier: | 1H-indole-4-carbaldehyde |
|
 | | LWI | | Name: | 2-(aminomethyl)-L-phenylalanine | | Formula: | C10 H14 N2 O2 | | SMILES: | NC(Cc1ccccc1CN)C(O)=O | | InChi: | InChI=1S/C10H14N2O2/c11-6-8-4-2-1-3-7(8)5-9(12)10(13)14/h1-4,9H,5-6,11-12H2,(H,13,14)/t9-/m0/s1 | | Definition date: | 2020-06-09 | | Last modified: | 2023-11-03 | | Release date: | 2021-03-31 | | Identifier: | 2-(aminomethyl)-L-phenylalanine |
|
 | | LWO | | Name: | 2-(1H-benzotriazol-1-yl)-N-[4-(methylamino)phenyl]-N-[(thiophen-3-yl)methyl]acetamide | | Formula: | C20 H19 N5 O S | | SMILES: | O=C(Cn1nnc2ccccc21)N(Cc1ccsc1)c1ccc(NC)cc1 | | InChi: | InChI=1S/C20H19N5OS/c1-21-16-6-8-17(9-7-16)24(12-15-10-11-27-14-15)20(26)13-25-19-5-3-2-4-18(19)22-23-25/h2-11,14,21H,12-13H2,1H3 | | Definition date: | 2023-08-15 | | Last modified: | 2023-11-03 | | Release date: | 2023-11-08 | | Identifier: | 2-(1H-benzotriazol-1-yl)-N-[4-(methylamino)phenyl]-N-[(thiophen-3-yl)methyl]acetamide |
|
 | | 6FL | | Name: | 5,5,5,5',5',5'-hexafluoro-L-leucine | | Formula: | C6 H7 F6 N O2 | | SMILES: | FC(F)(F)C(CC(N)C(=O)O)C(F)(F)F | | InChi: | InChI=1S/C6H7F6NO2/c7-5(8,9)3(6(10,11)12)1-2(13)4(14)15/h2-3H,1,13H2,(H,14,15)/t2-/m0/s1 | | Definition date: | 2011-10-13 | | Last modified: | 2023-11-03 | | Identifier: | 5,5,5,5',5',5'-hexafluoro-L-leucine |
|
 | | LXF | | Name: | N-{4-[(2-phenylethyl)sulfamoyl]-1,3-benzothiazol-2-yl}acetamide | | Formula: | C17 H17 N3 O3 S2 | | SMILES: | O=S(=O)(NCCc1ccccc1)c1cccc2sc(nc12)NC(C)=O | | InChi: | InChI=1S/C17H17N3O3S2/c1-12(21)19-17-20-16-14(24-17)8-5-9-15(16)25(22,23)18-11-10-13-6-3-2-4-7-13/h2-9,18H,10-11H2,1H3,(H,19,20,21) | | Definition date: | 2023-08-15 | | Last modified: | 2023-11-03 | | Release date: | 2023-11-08 | | Identifier: | N-{4-[(2-phenylethyl)sulfamoyl]-1,3-benzothiazol-2-yl}acetamide |
|
 | | LYF | | Name: | (2E,4S)-2-{[(5S)-5-amino-5-carboxypentyl]imino}-4-hydroxyheptanedioic acid | | Formula: | C13 H22 N2 O7 | | SMILES: | O=C(O)C(N)CCCC/N=C(/C(=O)O)CC(O)CCC(=O)O | | InChi: | InChI=1S/C13H22N2O7/c14-9(12(19)20)3-1-2-6-15-10(13(21)22)7-8(16)4-5-11(17)18/h8-9,16H,1-7,14H2,(H,17,18)(H,19,20)(H,21,22)/b15-10+/t8-,9-/m0/s1 | | Definition date: | 2011-10-25 | | Last modified: | 2023-11-03 | | Identifier: | (2E,4S)-2-{[(5S)-5-amino-5-carboxypentyl]imino}-4-hydroxyheptanedioic acid |
|
 | | LYH | | Name: | 3,4 ENE-LYSINE | | Formula: | C6 H12 N2 O2 | | SMILES: | O=C(O)C(/C=C/CCN)N | | InChi: | InChI=1S/C6H12N2O2/c7-4-2-1-3-5(8)6(9)10/h1,3,5H,2,4,7-8H2,(H,9,10)/b3-1+/t5-/m0/s1 | | Synonyms: | (2S,3E)-2,6-DIAMINOHEX-3-ENOIC ACID | | Definition date: | 2011-03-14 | | Last modified: | 2023-11-03 | | Release date: | 2012-08-24 | | Identifier: | (2S,3E)-2,6-diaminohex-3-enoic acid |
|
 | | LYJ | | Name: | (2S)-2,6-diaminohexan-1-ol | | Formula: | C6 H16 N2 O | | SMILES: | OCC(N)CCCCN | | InChi: | InChI=1S/C6H16N2O/c7-4-2-1-3-6(8)5-9/h6,9H,1-5,7-8H2/t6-/m0/s1 | | Definition date: | 2012-01-18 | | Last modified: | 2023-11-03 | | Identifier: | (2S)-2,6-diaminohexan-1-ol |
|
 | | LYK | | Name: | (2S)-2,6-diaminohexane-1,1-diol | | Formula: | C6 H16 N2 O2 | | SMILES: | OC(O)C(N)CCCCN | | InChi: | InChI=1S/C6H16N2O2/c7-4-2-1-3-5(8)6(9)10/h5-6,9-10H,1-4,7-8H2/t5-/m0/s1 | | Definition date: | 2010-10-08 | | Last modified: | 2023-11-03 | | Identifier: | (2S)-2,6-diaminohexane-1,1-diol |
|
 | | LYO | | Name: | 4-HYDROXY-LYSINE | | Formula: | C6 H14 N2 O3 | | SMILES: | O=C(O)C(N)CC(O)CCN | | InChi: | InChI=1S/C6H14N2O3/c7-2-1-4(9)3-5(8)6(10)11/h4-5,9H,1-3,7-8H2,(H,10,11)/t4-,5-/m0/s1 | | Definition date: | 2011-03-30 | | Last modified: | 2023-11-03 | | Release date: | 2012-10-19 | | Identifier: | (4S)-4-hydroxy-L-lysine |
|
 | | LYP | | Name: | N~6~-METHYL-N~6~-PROPYL-L-LYSINE | | Formula: | C10 H22 N2 O2 | | SMILES: | O=C(O)C(N)CCCCN(CCC)C | | InChi: | InChI=1S/C10H22N2O2/c1-3-7-12(2)8-5-4-6-9(11)10(13)14/h9H,3-8,11H2,1-2H3,(H,13,14)/t9-/m0/s1 | | Definition date: | 2007-03-28 | | Last modified: | 2023-11-03 | | Identifier: | N~6~-methyl-N~6~-propyl-L-lysine |
|
 | | LYS | | Name: | LYSINE | | Formula: | C6 H15 N2 O2 | | SMILES: | O=C(O)C(N)CCCC[NH3+] | | InChi: | InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/p+1/t5-/m0/s1 | | Definition date: | 1999-07-08 | | Last modified: | 2023-11-03 | | Identifier: | 6-ammonio-L-norleucine |
|
 | | LYV | | Name: | O-phosphono-L-seryl-N-[(3S)-3-amino-3-carboxypropyl]glycinamide | | Formula: | C9 H19 N4 O8 P | | SMILES: | O=P(OCC(C(=O)NCC(=O)NCCC(C(=O)O)N)N)(O)O | | InChi: | InChI=1S/C9H19N4O8P/c10-5(9(16)17)1-2-12-7(14)3-13-8(15)6(11)4-21-22(18,19)20/h5-6H,1-4,10-11H2,(H,12,14)(H,13,15)(H,16,17)(H2,18,19,20)/t5-,6-/m0/s1 | | Definition date: | 2013-12-06 | | Last modified: | 2023-11-03 | | Release date: | 2014-12-03 | | Identifier: | O-phosphono-L-seryl-N-[(3S)-3-amino-3-carboxypropyl]glycinamide |
|
 | | LYZ | | Name: | 5-HYDROXYLYSINE | | Formula: | C6 H14 N2 O3 | | SMILES: | O=C(O)C(N)CCC(O)CN | | InChi: | InChI=1S/C6H14N2O3/c7-3-4(9)1-2-5(8)6(10)11/h4-5,9H,1-3,7-8H2,(H,10,11)/t4-,5+/m1/s1 | | Definition date: | 1999-07-08 | | Last modified: | 2023-11-03 | | Identifier: | (5R)-5-hydroxy-L-lysine |
|
 | | LZX | | Name: | (2R)-4-[(methanesulfonyl)amino]-2-phenyl-N-(pyridin-3-yl)butanamide | | Formula: | C16 H19 N3 O3 S | | SMILES: | O=C(Nc1cccnc1)C(CCNS(C)(=O)=O)c1ccccc1 | | InChi: | InChI=1S/C16H19N3O3S/c1-23(21,22)18-11-9-15(13-6-3-2-4-7-13)16(20)19-14-8-5-10-17-12-14/h2-8,10,12,15,18H,9,11H2,1H3,(H,19,20)/t15-/m1/s1 | | Definition date: | 2023-08-15 | | Last modified: | 2023-11-03 | | Release date: | 2023-11-08 | | Identifier: | (2R)-4-[(methanesulfonyl)amino]-2-phenyl-N-(pyridin-3-yl)butanamide |
|
 | | M0G | | Name: | (2S)-2-(3-chlorophenyl)-2-hydroxy-N-(4-methylpyridin-3-yl)butanamide | | Formula: | C16 H17 Cl N2 O2 | | SMILES: | O=C(Nc1cnccc1C)C(O)(CC)c1cccc(Cl)c1 | | InChi: | InChI=1S/C16H17ClN2O2/c1-3-16(21,12-5-4-6-13(17)9-12)15(20)19-14-10-18-8-7-11(14)2/h4-10,21H,3H2,1-2H3,(H,19,20)/t16-/m0/s1 | | Definition date: | 2023-08-15 | | Last modified: | 2023-11-03 | | Release date: | 2023-11-08 | | Identifier: | (2S)-2-(3-chlorophenyl)-2-hydroxy-N-(4-methylpyridin-3-yl)butanamide |
|
 | | M0H | | Name: | S-(HYDROXYMETHYL)-L-CYSTEINE | | Formula: | C4 H9 N O3 S | | SMILES: | O=C(O)C(N)CSCO | | InChi: | InChI=1S/C4H9NO3S/c5-3(4(7)8)1-9-2-6/h3,6H,1-2,5H2,(H,7,8)/t3-/m0/s1 | | Definition date: | 2007-04-30 | | Last modified: | 2023-11-03 | | Identifier: | S-(hydroxymethyl)-L-cysteine |
|
 | | M0X | | Name: | 2-(1H-benzotriazol-1-yl)-N-[4-(dimethylamino)phenyl]-N-[(thiophen-3-yl)methyl]acetamide | | Formula: | C21 H21 N5 O S | | SMILES: | O=C(Cn1nnc2ccccc21)N(Cc1ccsc1)c1ccc(cc1)N(C)C | | InChi: | InChI=1S/C21H21N5OS/c1-24(2)17-7-9-18(10-8-17)25(13-16-11-12-28-15-16)21(27)14-26-20-6-4-3-5-19(20)22-23-26/h3-12,15H,13-14H2,1-2H3 | | Definition date: | 2023-08-15 | | Last modified: | 2023-11-03 | | Release date: | 2023-11-08 | | Identifier: | 2-(1H-benzotriazol-1-yl)-N-[4-(dimethylamino)phenyl]-N-[(thiophen-3-yl)methyl]acetamide |
|
 | | 5BV | | Name: | (2R,3R)-3-(glycyloxy)-2-methylnonanoic acid | | Formula: | C12 H23 N O4 | | SMILES: | O=C(OC(C(C)C(=O)O)CCCCCC)CN | | InChi: | InChI=1S/C12H23NO4/c1-3-4-5-6-7-10(9(2)12(15)16)17-11(14)8-13/h9-10H,3-8,13H2,1-2H3,(H,15,16)/t9-,10-/m1/s1 | | Definition date: | 2015-09-03 | | Last modified: | 2023-11-03 | | Release date: | 2016-03-02 | | Identifier: | (2R,3R)-3-(glycyloxy)-2-methylnonanoic acid |
|
 | | 5CT | | Name: | Hypusine | | Formula: | C10 H23 N3 O3 | | SMILES: | C(CCNCC(O)CCN)CC(C(=O)O)N | | InChi: | InChI=1S/C10H23N3O3/c11-5-4-8(14)7-13-6-2-1-3-9(12)10(15)16/h8-9,13-14H,1-7,11-12H2,(H,15,16)/t8-,9-/m0/s1 | | Synonyms: | N~6~-[(2S)-4-amino-2-hydroxybutyl]-L-lysine | | Definition date: | 2015-09-07 | | Last modified: | 2023-11-03 | | Release date: | 2016-01-20 | | Identifier: | N~6~-[(2S)-4-amino-2-hydroxybutyl]-L-lysine |
|
 | | 5CW | | Name: | 5-chloro-L-tryptophan | | Formula: | C11 H11 Cl N2 O2 | | SMILES: | O=C(O)C(N)Cc2c1cc(Cl)ccc1nc2 | | InChi: | InChI=1S/C11H11ClN2O2/c12-7-1-2-10-8(4-7)6(5-14-10)3-9(13)11(15)16/h1-2,4-5,9,14H,3,13H2,(H,15,16)/t9-/m0/s1 | | Definition date: | 2013-12-09 | | Last modified: | 2023-11-03 | | Release date: | 2014-03-05 | | Identifier: | 5-chloro-L-tryptophan |
|
 | | M26 | | Name: | N-[(1R)-1-(3-bromophenyl)-2-methoxyethyl]-2-[(3S)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-yl]acetamide | | Formula: | C19 H18 Br F N2 O3 | | SMILES: | Brc1cccc(c1)C(COC)NC(=O)CC1c2cc(F)ccc2NC1=O | | InChi: | InChI=1S/C19H18BrFN2O3/c1-26-10-17(11-3-2-4-12(20)7-11)22-18(24)9-15-14-8-13(21)5-6-16(14)23-19(15)25/h2-8,15,17H,9-10H2,1H3,(H,22,24)(H,23,25)/t15-,17-/m0/s1 | | Definition date: | 2023-08-15 | | Last modified: | 2023-11-03 | | Release date: | 2023-11-08 | | Identifier: | N-[(1R)-1-(3-bromophenyl)-2-methoxyethyl]-2-[(3S)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-yl]acetamide |
|
